ONPH is exploring strategic partnerships and opportunities in oncology
Our Portfolio (Licences - LOI)
Nanosmart Pharmaceuticals -
NanoSmart's® platform technology (US Patent No: 7,799,327 and EU 1706145 B1)
Social engagement and retention platform for clinical trials
Cancer therapy by intratumoral injection of a chemotherapeutic agent in combination with a bioactive immunostimulatory agent.
Small Molecule Check Point NR2F6
Antigen Specific mRNA Cellular Cancer Vaccines